journal article·2014-06

Enhancing the receptor-mediated cell uptake of PLGA nanoparticle for targeted drug delivery by incorporation chitosan onto the particle surface

Guoqiang Jiang, Shifu Tang, Xuelan Chen, Fuxin Ding

Journal of Nanoparticle Research· Volume 16· Issue 6
Publisher page

Abstract

Cationic polymer chitosan (CS) and target ligand were both incorporated onto nanoparticles (NPs) to enhance the cell uptake by integration of electrostatic interaction and receptor-mediated internalization. CS and biotin-contained amphipathic polymer biotin–poly(ethylene glycol)–poly(lactic acid) (biotin–PEG–PLA) were simultaneously decorated on the poly(lactic-co-glycolic acid) (PLGA) NPs surface in one step during the o/w solvent evaporation procedure. The incorporation of CS increased the zeta potential of the NPs to positive value and showed little impacts on particle size and biotin density. Cell uptake was investigated in vitro using human hepatic carcinoma cell lines SMMC-7721. The CS and biotin co-decorated NPs (CS-B-NPs) presented significantly higher cell uptake than that of the mono biotin-decorated NPs (B-NPs). In acid environment, as CS-B-NPs are more positive charged, cell uptake of CS-B-NPs is further increased, which is 3.8-fold as much as that of the undecorated NPs (U-NPs) and 1.9-fold higher than that of B-NPs at pH 6.6. When either the ligand density was reduced within limited or the particle size was slightly increased, cell uptake of CS-B-NPs remained almost the same. The cell uptake mechanism study demonstrated that the internalization due to the electrostatic interaction would contribute more to the cell uptake when the internalization based on clathrin-mediated endocytosis and other ATP-dependent pathways were blocked. The co-decoration of CS and target ligand is an effective approach for improving the specific cell uptake of NPs.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. Allen TM (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2:750–76310.1038/nrc903 ↗
2. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W (1995) Ovarian angiogenesis phenotypic-characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 147:339–351
3. Bandyopadhyay A, Fine RL, Demento S, Bockenstedt LK, Fahmy TM (2011) The impact of nanoparticle ligand density on dendritic-cell targeted vaccines. Biomaterials 32:3094–310510.1016/j.biomaterials.2010.12.054 ↗
4. Byrne JD, Betancourt T, Brannon-Peppas L (2008) Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–162610.1016/j.addr.2008.08.005 ↗
5. Chung Y, Kim JC, Kim YH, Tae G, Lee S-Y, Kim K, Kwon IC (2010) The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. J Controll Release 143:374–38210.1016/j.jconrel.2010.01.017 ↗
6. Decuzzi P, Ferrari M (2008) The receptor-mediated endocytosis of nonspherical particles. Biophys J 94:3790–379710.1529/biophysj.107.120238 ↗
7. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–90210.1146/annurev.biochem.78.081307.110540 ↗
8. Duan JH, Liu MJ, Zhang YD, Zhao JF, Pan YF, Yang XY (2012) Folate-decorated chitosan/doxorubicin poly(butyl)cyanoacrylate nanoparticles for tumor-targeted drug delivery. J Nanopart Res 14:761–76910.1007/s11051-012-0761-4 ↗
9. Elias DR, Poloukhtine A, Popik V, Tsourkas A (2013) Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine 9:194–20110.1016/j.nano.2012.05.015 ↗
10. Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD (1995) Extracellular pH distribution in human tumours. Int J Hyperth 11:211–21610.3109/02656739509022457 ↗
11. Fakhari A, Baoum A, Siahaan TJ, Le KB, Berkland C (2011) Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. J Pharm Sci 100:1045–105610.1002/jps.22342 ↗
12. Gref R, Couvreur P, Barratt G, Mysiakine E (2003) Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 24:4529–453710.1016/S0142-9612(03)00348-X ↗
13. Hillaireau H, Couvreur P (2009) Nanocarriers’ entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66:2873–289610.1007/s00018-009-0053-z ↗
14. Huang M, Ma ZS, Khor E, Lim LY (2002) Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res 19:1488–149410.1023/A:1020404615898 ↗
15. Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145–15010.1038/nnano.2008.30 ↗
16. Johnston APR, Such GK, Ng SL, Caruso F (2011) Challenges facing colloidal delivery systems: from synthesis to the clinic. Curr Opin Colloid Interface Sci 16:171–18110.1016/j.cocis.2010.11.003 ↗
17. Karra N, Benita S (2012) The ligand nanoparticle conjugation approach for targeted cancer therapy. Curr Drug Metab 13:22–4110.2174/138920012798356899 ↗
18. Kim SY, Cho SH, Lee YM, Chu LY (2007) Biotin-conjugated block copolymeric nanoparticles as tumor-targeted drug delivery systems. Macromol Res 15:646–65510.1007/BF03218945 ↗
19. Koo H, Huh MS, Sun I-C, Yuk SH, Choi K, Kim K, Kwon IC (2011) In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res 44:1018–102810.1021/ar2000138 ↗
20. Manoochehri S, Darvishi B, Kamalinia G, Amini M, Fallah M, Ostad SN, Atyabi F, Dinarvand R (2013) Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU J Pharm Sci 21:66–7310.1186/2008-2231-21-66 ↗
21. Morachis JM, Mahmoud EA, Almutairi A (2012) Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles. Pharmacol Rev 64:505–51910.1124/pr.111.005363 ↗
22. Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM (2007) Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine 3:173–18310.1016/j.nano.2007.03.006 ↗
23. Panyam J, Labhasetwar V (2003) Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20:212–22010.1023/A:1022219003551 ↗
24. Patil YB, Toti US, Khdair A, Ma L, Panyam J (2009) Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 30:859–86610.1016/j.biomaterials.2008.09.056 ↗
25. Pho MT, Ashok A, Atwood WJ (2000) JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 74:2288–229210.1128/JVI.74.5.2288-2292.2000 ↗
26. Ran S, Thorpe PE (2002) Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys 54:1479–148410.1016/S0360-3016(02)03928-7 ↗
27. Sapsford KE, Algar WR, Berti L, Gemmill KB, Casey BJ, Oh E, Stewart MH, Medintz IL (2013) Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem Rev 113:1904–207410.1021/cr300143v ↗
28. Shen M, Huang YZ, Han LM, Qin J, Fang XL, Wang JX, Yang VC (2012) Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. J Control Release 161:884–89210.1016/j.jconrel.2012.05.013 ↗
29. Torchilin VP, Rammohan R, Weissig V, Levchenko TS (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA 98:8786–879110.1073/pnas.151247498 ↗
30. Vangara KK, Liu JL, Palakurthi S (2013) Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer Res 33:2425–2434
31. Vyas SP, Singh A, Sihorkar V (2001) Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst 18:1–7610.1615/CritRevTherDrugCarrierSyst.v18.i6.10 ↗
32. Wang M, Thanou M (2010) Targeting nanoparticles to cancer. Pharmacol Res 62:90–9910.1016/j.phrs.2010.03.005 ↗
33. Wang Y, Jiang G, Qiu T, Ding F (2012) Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery. Drug Dev Ind Pharm 38:1039–104610.3109/03639045.2011.637052 ↗
34. Xu S, Olenyuk BZ, Okamoto CT, Hamm-Alvarez SF (2013) Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev 65:121–13810.1016/j.addr.2012.09.041 ↗
35. Yang R, Shim W-S, Cui F-D, Cheng G, Han X, Jin Q-R, Kim D-D, Chung S-J, Shim C-K (2009) Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int J Pharm 371:142–14710.1016/j.ijpharm.2008.12.007 ↗